Publications 2024

Davidson B, Skeie-Jensen T, Holth A, Hausladen S (2024)
Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma
Int J Gynecol Pathol (in press)
DOI 10.1097/PGP.0000000000001030, PubMed 38847524

Publications 2023

Davidson B, Skeie-Jensen T, Holth A, Lindemann K, Toralba Barrameda AM, Lie AK, Wang Y (2023)
Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma
Virchows Arch, 484 (6), 951-963
DOI 10.1007/s00428-023-03670-y, PubMed 37843640

Valstad H, Eyjolfsdottir B, Wang Y, Kristensen GB, Skeie-Jensen T, Lindemann K (2023)
Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis
Eur J Surg Oncol, 49 (9), 106958
DOI 10.1016/j.ejso.2023.06.010, PubMed 37349160

Publications 2020

Sharma A, Davidson B, Skeie-Jensen T, Wang Y (2020)
Fifteen Years’ Experience with Vulvar Verrucous Carcinoma at a Single Norwegian Academic Cancer Center
Journal of Gynecology and Women Healthcare, 2 (2), 1-4
PublikaID 489

Vistad I, Bjørge L, Skeie-Jensen T (2020)
Need for change in cancer follow-up
Tidsskr Nor Laegeforen, 140
DOI 10.4045/tidsskr.20.0281, PubMed 32323956

Publications 2017

Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)
Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma
Virchows Arch, 471 (3), 355-362
DOI 10.1007/s00428-017-2172-5, PubMed 28643014

Hardell E, Josefson S, Ghaderi M, Skeie-Jensen T, Westbom-Fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Måsbäck A, Davidson B, Carlson JW (2017)
Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas
Am J Surg Pathol, 41 (9), 1231-1237
DOI 10.1097/PAS.0000000000000894, PubMed 28622181

Lindemann K, Gibbs E, Åvall-Lundqvist E, dePont Christensen R, Woie K, Kalling M, Auranen A, Grenman S, Hoegberg T, Rosenberg P, Skeie-Jensen T, Hjerpe E, Dørum A, Gebski V, Kristensen G (2017)
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
Br J Cancer, 116 (4), 455-463
DOI 10.1038/bjc.2016.435, PubMed 28118323

Publications 2012

Davidson B, Abeler VM, Hellesylt E, Holth A, Shih IeM, Skeie-Jensen T, Chen L, Yang Y, Wang TL (2012)
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma
Gynecol Oncol, 128 (2), 349-55
DOI 10.1016/j.ygyno.2012.11.021, PubMed 23178314

Lee CK, Simes RJ, Brown C, Gebski V, Pfisterer J, Swart AM, Berton-Rigaud D, Plante M, Skeie-Jensen T, Vergote I, Schauer C, Pisano C, Parma G, Baumann K, Ledermann JA, Pujade-Lauraine E, Bentley J, Kristensen G, Belau A, Nankivell M, Canzler U, Lord SJ, Kurzeder C, Friedlander M (2012)
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer
Ann Oncol, 24 (4), 937-43
DOI 10.1093/annonc/mds538, PubMed 23104722

Publications 1997

Aarli A, Skeie Jensen T, Kristoffersen EK, Bakke A, Ulvestad E (1997)
Inhibition of phytohaemagglutinin-induced lymphoproliferation by soluble annexin II in sera from patients with renal cell carcinoma
APMIS, 105 (9), 699-704
DOI 10.1111/j.1699-0463.1997.tb05073.x, PubMed 9350213

Publications 1993

Ulstein M, Skeie Jensen T, Matre R (1993)
Demonstration of Fc gamma receptors in human endometrium
Acta Obstet Gynecol Scand, 72 (1), 4-9
DOI 10.3109/00016349309013340, PubMed 8382431

Aarli A, Skeie Jensen T, Ulvestad E, Matre R (1993)
Suppression of mitogen-induced lymphoproliferation by soluble IgG Fc receptors in retroplacental serum in normal human pregnancy
Scand J Immunol, 37 (2), 237-43
DOI 10.1111/j.1365-3083.1993.tb01761.x, PubMed 8434234

Publications 1991

Irgens LM, Lie RT, Ulstein M, Skeie Jensen T, Skjaerven R, Sivertsen F, Reitan JB, Strand F, Strand T, Egil Skjeldestad F (1991)
Pregnancy outcome in Norway after Chernobyl
Biomed Pharmacother, 45 (6), 233-41
DOI 10.1016/0753-3322(91)90023-m, PubMed 1912379